glucose, (beta-d)-isomer has been researched along with Gaucher Disease in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (68.75) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levy, R; Liel, Y; Nagauker-Shriker, O; Rudich, A; Yermiyahu, T | 1 |
| Abrahamov, A; Aker, M; Horowitz, M; Matzner, Y; Zimran, A | 1 |
| Buzueva, II; Falameeva, OV; Filyushina, EE; Kaledin, VI; Korolenko, TA; Paul, GA; Zhanaeva, SY | 1 |
| Castilla, J; Castillón, S; Díaz, Y; García Fernández, JM; Higaki, K; Nanba, E; Ohno, K; Ortiz Mellet, C; Rísquez, R; Suzuki, Y | 1 |
| Blech-Hermoni, Y; Felderhoff-Mueser, U; Goldin, E; Harzer, K; Igney, C; Sidransky, E; Yildiz, Y | 1 |
| Déchelotte, P | 1 |
| Adamski-Werner, SL; Beutler, E; Cheng, WC; Kelly, JW; Sawkar, AR; Wong, CH; Zimmer, KP | 1 |
| Desnick, RJ; Fabbro, D; Gatt, S | 1 |
| Kolodny, EH; Raghavan, SS; Topol, J | 1 |
| Dreborg, S; Håkansson, G; Svennerholm, L | 1 |
| Kumin, S; Nakagawa, S; Nitowsky, HM; Sachs, G | 1 |
| Daniels, LB; Glew, RH | 1 |
| Desnick, RJ; Dinur, T; Gatt, S | 1 |
| Barns, RJ; Clague, AE | 1 |
| Gal, AE; Johnson, WG; Miranda, AF; Pentchev, PG | 1 |
| Dudukina, TV; Karpova, EA; Tsvetkova, IV; Voznyi, YV | 1 |
| Aerts, JM; Mikhaylov, V; Mikhaylova, M; Wiederschain, G | 1 |
| Havenga, M; Valerio, D; van Es, HH; Veldwijk, M | 1 |
| Broadhead, DM; Butterworth, J | 1 |
| Radin, NS | 1 |
| Ben-Yoseph, Y; Nadler, HL | 1 |
| McCluer, RH; Ullman, MD | 1 |
| Ariga, T; Miyatake, T; Murata, T; Oshima, M | 1 |
| Kanfer, JN; Labow, RS; Layne, DS; legler, G; Mumford, RA; Raghaven, SS; Sullivan, J; Williamson, DG | 1 |
| Oshima, M | 1 |
| Fash, FJ; Gal, AE; Pentchev, PG | 1 |
| Aerts, JM; Barranger, JA; Donker-Koopman, WE; Koot, M; Schram, AW; Tager, JM | 1 |
| Desnick, RJ; Fabbro, D; Grabowski, GA; Legler, G; Osiecki-Newman, K | 1 |
| Bouillon, L; Choy, FY; Laurin, CA | 1 |
| Carroll, M | 1 |
| Desnick, RJ; Dinur, T; Gatt, S; Grabowski, GA; Osiecki, K | 1 |
| Basu, A; Glew, RH | 1 |
32 other study(ies) available for glucose, (beta-d)-isomer and Gaucher Disease
| Article | Year |
|---|---|
Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation.
Topics: Adult; Aged; Chemotaxis; Female; Gaucher Disease; Glucosylceramides; Granulocytes; Humans; Male; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitroblue Tetrazolium; Opsonin Proteins; Oxidation-Reduction; Phagocytes; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
Abnormal neutrophil chemotaxis in Gaucher disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Chemotaxis, Leukocyte; Child; Child, Preschool; Female; Gaucher Disease; Genotype; Humans; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Zymosan | 1993 |
Chitotriosidase as a marker of macrophage stimulation.
Topics: Adolescent; Adult; Animals; beta-Glucans; Biomarkers; Case-Control Studies; Child; Child, Preschool; Gaucher Disease; Glucans; Hexosaminidases; Humans; Infant; Kupffer Cells; Lipid Metabolism; Lymphoma, Non-Hodgkin; Lysosomes; Macrophages; Male; Mice; Mice, Inbred CBA; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Polyethylene Glycols; Rats; Rats, Wistar; Zymosan | 2000 |
Conformationally-locked N-glycosides: exploiting long-range non-glycone interactions in the design of pharmacological chaperones for Gaucher disease.
Topics: Carbohydrate Conformation; Drug Design; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Molecular Chaperones; Oxazoles | 2015 |
Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
Topics: Animals; beta-Glucosidase; Bile Acids and Salts; Brain; Fibroblasts; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Hydrolysis; Liver; Male; Mice | 2012 |
[Type 1 Gaucher's disease in the adult. Nutritional management during initiation of treatment with miglustat].
Topics: Adult; Antidiarrheals; Combined Modality Therapy; Diarrhea; Dietary Carbohydrates; Disaccharides; Dose-Response Relationship, Drug; Fructose; Gastrointestinal Transit; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Loperamide; Malabsorption Syndromes; Monosaccharides; Probiotics; Recombinant Proteins; Risk Factors | 2004 |
Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Topics: Alkylation; Cells, Cultured; Gaucher Disease; Gene Expression Profiling; Glucose; Glucosides; Glucosylceramidase; Glycosylation; Humans; Kinetics; Lysosomes; Molecular Structure; Mutation; Protein Folding | 2005 |
Lysosomal beta-glucosidase of rat liver.
Topics: Animals; beta-Glucosidase; Gaucher Disease; Glucosidases; Glucosides; Humans; Hymecromone; Liver; Lysosomes; Male; Rats; Rats, Inbred Strains; Solubility; Species Specificity; Subcellular Fractions | 1984 |
Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
Topics: Adult; beta-Glucosidase; Child; Chromatography, Gel; Detergents; Female; Gaucher Disease; Genetic Carrier Screening; Glucosidases; Glucosides; Heterozygote; Homozygote; Humans; Hydrogen-Ion Concentration; Hymecromone; Isoenzymes; Kidney; Kinetics; Leukocytes; Liver; Male; Temperature | 1980 |
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
Topics: Acetylglucosamine; Acetylglucosaminidase; Adolescent; Adult; Age Factors; Aged; beta-Galactosidase; beta-Glucosidase; Child; Child, Preschool; Drug Stability; Female; Galactosides; Gaucher Disease; Glucosamine; Glucosidases; Glucosides; Glucosylceramidase; Heterozygote; Homozygote; Humans; Hymecromone; Leukocytes; Male; Middle Aged; Sex Factors | 1980 |
Heterozygote detection of type I Gaucher disease using blood platelets.
Topics: Adult; beta-Glucosidase; Blood Platelets; Gaucher Disease; Genetic Carrier Screening; Glucosides; Hexosaminidases; Homozygote; Humans; Hydrogen-Ion Concentration; Hymecromone; Kinetics; Leukocytes; Taurocholic Acid | 1982 |
beta-Glucosidase assays in the diagnosis of Gaucher's disease.
Topics: beta-Glucosidase; Clinical Enzyme Tests; Gaucher Disease; Glucosidases; Glucosides; Heterozygote; Humans; Hymecromone; Isoenzymes; Leukocytes | 1982 |
Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
Topics: beta-Glucosidase; Detergents; Europe; Gaucher Disease; Glucosidases; Glucosides; Humans; Hydrolysis; Inositol; Jews; Psychosine | 1982 |
An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.
Topics: Cells, Cultured; Fibroblasts; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Glycosides; Humans; Hymecromone; Methods; Skin; Substrate Specificity | 1982 |
Diagnosis of adult Gaucher disease: use of a new chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside, in cultured skin fibroblasts.
Topics: Adult; Cells, Cultured; Clinical Enzyme Tests; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Glycosides; Heterozygote; Histocytochemistry; Humans; Jews; Skin | 1980 |
4-Pentafluoroethylumbelliferyl-beta-D-glucoside as a new fluorogenic substrate for acid beta-D-glucosidase.
Topics: beta-Glucosidase; Fluorescent Dyes; Gaucher Disease; Glucosides; Humans; Hydrogen-Ion Concentration; Hymecromone; Kinetics; Leukocytes; Magnetic Resonance Spectroscopy; Molecular Structure; Spectrophotometry; Umbelliferones | 1996 |
The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
Topics: Animals; beta-Glucosidase; Chromatography, Agarose; Chromatography, Gel; Fibroblasts; Fluorescence; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hymecromone; Isoelectric Point; Kidney; Liver; Lysosomes; Rats; Spleen; Subcellular Fractions; Substrate Specificity | 1996 |
A flow cytometric assay for lysosomal glucocerebrosidase.
Topics: Animals; Cell Line; Flow Cytometry; Fluorescein; Fluoresceins; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Lysosomes; Mice; Recombinant Proteins; Transfection | 1997 |
The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
Topics: Gaucher Disease; Glucosidases; Glucosides; Glucuronidase; Humans; Hydrogen-Ion Concentration; Hymecromone; Liver; Umbelliferones | 1977 |
Inhibitors of beta-glucosidases of animal tissues.
Topics: Animals; beta-Glucosidase; Cell Line; Cerebrosides; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Humans; Phlorhizin; Rats; Sphingosine; Spleen; Structure-Activity Relationship | 1978 |
Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
Topics: Adult; beta-Glucosidase; Clinical Enzyme Tests; Female; Fibroblasts; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramides; Humans; Hymecromone; Leukocytes; Liver | 1978 |
Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives.
Topics: Benzyl Compounds; Chromatography, High Pressure Liquid; Fabry Disease; Gaucher Disease; Glucosides; Glycolipids; Glycosphingolipids; Humans; Leukodystrophy, Globoid Cell | 1977 |
Characterization of trimethylsilyl derivatives of cerebrosides by direct inlet-chemical ionization mass spectrometry.
Topics: Animals; Brain Chemistry; Cattle; Cerebrosides; Fatty Acids; Galactosides; Gaucher Disease; Glucosides; Humans; Hydroxy Acids; Mass Spectrometry; Spleen; Trimethylsilyl Compounds | 1978 |
Recent observations on Gaucher's disease.
Topics: Aging; Animals; Brain; Ceramides; Disease Models, Animal; Estradiol; Gaucher Disease; Glucosides; Glucosylceramidase; Glycoside Hydrolases; Humans; Infant; Kinetics; Liver; Lysosomes; Mice; Sphingolipids; Sphingosine; Spleen | 1976 |
Identification of glucosyl sphingosine from Gaucher's spleen by gas chromatography-electron impact and GC-chemical ionization mass spectrometry.
Topics: Adult; Female; Gas Chromatography-Mass Spectrometry; Gaucher Disease; Glucosides; Glycosides; Humans; Sphingosine; Spleen | 1976 |
A novel chromogenic substrate for assaying glucocerebrosidase activity.
Topics: Cerebrosides; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Humans; Kinetics; Methods; Nitrophenols; Placenta; Spleen | 1976 |
Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.
Topics: Adolescent; Adult; beta-N-Acetylhexosaminidases; Child; Female; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Hexosaminidases; Humans; Hymecromone; Inositol; Male; Middle Aged; Substrate Specificity | 1986 |
Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Topics: 1-Deoxynojirimycin; Amines; beta-Glucosidase; Binding Sites; Binding, Competitive; Ceramides; Female; Gaucher Disease; Glucosamine; Glucosidases; Glucosides; Humans; Kinetics; Octoxynol; Placenta; Polyethylene Glycols; Pregnancy; Sphingosine; Spleen; Structure-Activity Relationship | 1987 |
Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
Topics: Adult; Cerebrosides; Clinical Enzyme Tests; Female; Fibroblasts; Gaucher Disease; Genetic Carrier Screening; Glucosides; Glucosylceramidase; Glucosylceramides; Glycosides; Humans; Hymecromone; Lymphocytes; Male; Pedigree; Quebec; Umbelliferones | 1987 |
Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
Topics: beta-Glucosidase; Cell Membrane; Concanavalin A; Gaucher Disease; Glucosidases; Glucosides; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hymecromone; Kinetics; Liposomes; Molecular Weight; Phosphatidylcholines; Solubility; Spleen | 1985 |
Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Topics: beta-Glucosidase; Binding Sites; Enzyme Activation; Gaucher Disease; Glucosidases; Glucosides; Humans; Kinetics; Lymphocytes; Lysosomes; Phosphatidylserines; Psychosine; Spleen; Taurocholic Acid | 1985 |
Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
Topics: Animals; beta-Glucosidase; Chemical Phenomena; Chemistry, Physical; Dose-Response Relationship, Drug; Enzyme Activation; G(M1) Ganglioside; Gangliosides; Gaucher Disease; Glucosidases; Glucosides; Hot Temperature; Humans; Hymecromone; Inositol; Kinetics; Liver; Lysosomes; Male; Micelles; Molecular Weight; Rats; Rats, Inbred Strains; Temperature | 1985 |